170 related articles for article (PubMed ID: 19480853)
21. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
23. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines.
Watanabe H; Iwase M; Ohashi M; Nagumo M
Oral Oncol; 2002 Oct; 38(7):670-9. PubMed ID: 12167419
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of vascular endothelial growth factor expression in patients with carcinoma of the mouth floor and tongue.
Broćić M; Kozomara R; Cerović S; Jović N; Vukelić-Marković S; Stosić S
Vojnosanit Pregl; 2009 Jun; 66(6):440-8. PubMed ID: 19583141
[TBL] [Abstract][Full Text] [Related]
25. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of CoCl2 induced hypoxic cell model of oral squamous cell carcinoma and a preliminary study on the biological behaviour change].
Han S; Han W; Ni Y; Wang Z; Hu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Mar; 50(3):173-7. PubMed ID: 26081859
[TBL] [Abstract][Full Text] [Related]
28. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
29. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
30. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood dendritic cells and vascular endothelial growth factor in oral squamous cell carcinoma: correlation analysis and in vitro study.
Wang ZY; Shi PH; Huang XF; Hua ZC; Hou YY; Han W; Hu QG
Int J Oral Maxillofac Surg; 2010 Jul; 39(7):713-20. PubMed ID: 20395112
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance.
Aggarwal S; Devaraja K; Sharma SC; Das SN
Clin Chim Acta; 2014 Sep; 436():35-40. PubMed ID: 24833243
[TBL] [Abstract][Full Text] [Related]
33. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma.
Wei H; Hongya P; Linlin J; Mujiang A; Kuijie W; Duohong Z; Qingang H; Zhiyuan Z
Arch Oral Biol; 2011 Sep; 56(9):891-8. PubMed ID: 21474117
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor and dendritic cells in human squamous cell carcinoma of the oral cavity.
Kikuchi K; Kusama K; Sano M; Nakanishi Y; Ishige T; Ohni S; Oinuma T; Nemoto N
Anticancer Res; 2006; 26(3A):1833-48. PubMed ID: 16827115
[TBL] [Abstract][Full Text] [Related]
35. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
Hwang-Bo J; Park JH; Bae MG; Chung IS
Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
[TBL] [Abstract][Full Text] [Related]
36. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
Yang X; Wu H; Ling T
Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.
Ren JG; Zhang W; Liu B; Man QW; Xiong XP; Li C; Zhu JY; Wang WM; Jia J; Sun ZJ; Zhang WF; Chen G; Zhao YF
J Dent Res; 2016 Jul; 95(8):860-7. PubMed ID: 27013642
[TBL] [Abstract][Full Text] [Related]
39. Distinct expression of perforin and granzyme B in lip and oral cavity squamous cell carcinoma.
Costa NL; Gonçalves AS; Souza-Lima NC; Jaime-Paiva LG; Junqueira-Kipnis AP; Silva TA; Mendonça EF; Batista AC
J Oral Pathol Med; 2011 May; 40(5):380-4. PubMed ID: 21342273
[TBL] [Abstract][Full Text] [Related]
40. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.
Gasparoto TH; de Souza Malaspina TS; Benevides L; de Melo EJ; Costa MR; Damante JH; Ikoma MR; Garlet GP; Cavassani KA; da Silva JS; Campanelli AP
Cancer Immunol Immunother; 2010 Jun; 59(6):819-28. PubMed ID: 20012605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
